Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma-Reference-Cited by-同舟云学术

Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma

Published:2013-01-29 Issue:1 Volume:3 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Yamaki Tomohiro,Suenaga Yusuke,Iuchi Toshihiko,Alagu Jennifer,Takatori Atsushi,Itami Makiko,Araki Akinobu,Ohira Miki,Inoue Masahiro,Kageyama Hajime,Yokoi Sana,Saeki Naokatsu,Nakagawara Akira

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep01160.pdf

Reference33 articles.

1. Chen, J., McKay, R. M. & Parada, L. F. Malignant glioma: lessons from genomics, mouse models and stem cells. Cell 149, 36–47 (2012).

2. Mrugala, M. M. & Chamberlain, M. C. Mechanisms of disease: temozolomide and glioblastoma - look to the future. Nat. Clin. Pract. Oncol. 5, 476–486 (2008).

3. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005).

4. Hegi, M. E. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997–1003 (2005).

5. Shah, N. et al. Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM. PLoS One 6, e16146 (2011).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Key Signaling Pathways in Glioblastoma Stem Cells for the Development of Efficient Chemo- and Immunotherapy;International Journal of Molecular Sciences;2022-10-26

2. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO;CANCER RES;2022

3. FOXP3 Contributes to TMZ Resistance, Prognosis, and Immune Infiltration in GBM from a Novel Pyroptosis-Associated Risk Signature;Disease Markers;2022-04-01

4. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO;Cancer Research;2022-03-18

5. TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy;Cancers;2021-10-26